130 related articles for article (PubMed ID: 18274158)
1. Decreased matriptase/HAI-1 ratio in advanced colorectal adenocarcinoma of Chinese patients.
Tsai WC; Sheu LF; Chao YC; Chen A; Chiang H; Jin JS
Chin J Physiol; 2007 Oct; 50(5):225-31. PubMed ID: 18274158
[TBL] [Abstract][Full Text] [Related]
2. Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.
Zeng L; Cao J; Zhang X
World J Gastroenterol; 2005 Oct; 11(39):6202-7. PubMed ID: 16273651
[TBL] [Abstract][Full Text] [Related]
3. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
[TBL] [Abstract][Full Text] [Related]
4. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
5. The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.
Vogel LK; Saebø M; Skjelbred CF; Abell K; Pedersen ED; Vogel U; Kure EH
BMC Cancer; 2006 Jul; 6():176. PubMed ID: 16820046
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
Domoto T; Takino T; Guo L; Sato H
Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
[TBL] [Abstract][Full Text] [Related]
7. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.
Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H
Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538
[TBL] [Abstract][Full Text] [Related]
8. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
[TBL] [Abstract][Full Text] [Related]
10. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.
Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC
J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661
[TBL] [Abstract][Full Text] [Related]
12. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.
Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1.
Xu H; Xu Z; Tseng IC; Chou FP; Chen YW; Wang JK; Johnson MD; Kataoka H; Lin CY
Am J Physiol Cell Physiol; 2012 Jan; 302(2):C453-62. PubMed ID: 22031598
[TBL] [Abstract][Full Text] [Related]
14. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
[TBL] [Abstract][Full Text] [Related]
15. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.
Tseng IC; Chou FP; Su SF; Oberst M; Madayiputhiya N; Lee MS; Wang JK; Sloane DE; Johnson M; Lin CY
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C423-31. PubMed ID: 18550704
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin.
Lee SP; Kao CY; Chang SC; Chiu YL; Chen YJ; Chen MG; Chang CC; Lin YW; Chiang CP; Wang JK; Lin CY; Johnson MD
PLoS One; 2018; 13(2):e0192632. PubMed ID: 29438412
[TBL] [Abstract][Full Text] [Related]
18. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
[TBL] [Abstract][Full Text] [Related]
19. Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor-1.
Yamashita F; Kaieda T; Shimomura T; Kawaguchi M; Lin CY; Johnson MD; Tanaka H; Kiwaki T; Fukushima T; Kataoka H
FEBS J; 2022 Jun; 289(12):3422-3439. PubMed ID: 35020274
[TBL] [Abstract][Full Text] [Related]
20. 3-Cl-AHPC inhibits pro-HGF maturation by inducing matriptase/HAI-1 complex formation.
Ye F; Chen S; Liu X; Ye X; Wang K; Zeng Z; Su Y; Zhang XK; Zhou H
J Cell Mol Med; 2019 Jan; 23(1):155-166. PubMed ID: 30370662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
